Cargando…

Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus

PURPOSE: The aim of the present study was to evaluate the collective role of N-epsilon–carboxy methyl lysine (N(ε)-CML), advanced glycation end-products (AGEs), and reactive oxygen species (ROS) for the development of retinopathy among type 2 diabetic subjects. METHODS: Seventy type 2 diabetic subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhuri, Subhadip, Dutta, Deep, Sen, Aditi, Chowdhury, Imran Hussain, Mitra, Bhaskar, Mondal, Lakshmi Kanta, Saha, Avijit, Bhadhuri, Gautam, Bhattacharya, Basudev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559098/
https://www.ncbi.nlm.nih.gov/pubmed/23378723
_version_ 1782257509200822272
author Choudhuri, Subhadip
Dutta, Deep
Sen, Aditi
Chowdhury, Imran Hussain
Mitra, Bhaskar
Mondal, Lakshmi Kanta
Saha, Avijit
Bhadhuri, Gautam
Bhattacharya, Basudev
author_facet Choudhuri, Subhadip
Dutta, Deep
Sen, Aditi
Chowdhury, Imran Hussain
Mitra, Bhaskar
Mondal, Lakshmi Kanta
Saha, Avijit
Bhadhuri, Gautam
Bhattacharya, Basudev
author_sort Choudhuri, Subhadip
collection PubMed
description PURPOSE: The aim of the present study was to evaluate the collective role of N-epsilon–carboxy methyl lysine (N(ε)-CML), advanced glycation end-products (AGEs), and reactive oxygen species (ROS) for the development of retinopathy among type 2 diabetic subjects. METHODS: Seventy type 2 diabetic subjects with nonproliferative diabetic retinopathy (NPDR), 105 subjects with proliferative diabetic retinopathy (PDR), and 102 patients with diabetes but without retinopathy (DNR) were enrolled in this study. In addition, 95 normal individuals without diabetes were enrolled as healthy controls in this study. Serum and vitreous N(ε)-CML and AGEs were measured by enzyme-linked immunosorbent assay. The peripheral blood mononuclear cell (PBMC) ROS level was measured by flow cytometric analysis. Serum and PBMC total thiols were measured by spectrophotometry. RESULTS: Serum AGEs and N(ε)-CML levels were significantly elevated in subjects with PDR (p<0.0001) and NPDR (p=0.0297 and p<0.0001, respectively) compared to DNR subjects. Further vitreous AGEs and N(ε)-CML levels were found to be significantly high among PDR subjects compared to the control group (p<0.0001). PBMC ROS production was found to be strikingly high among NPDR (p<0.0001) and PDR (p<0.0001) subjects as compared to the DNR group. Serum and PBMC total thiol levels were remarkably decreased in NPDR (p<0.0001 and p=0.0043, respectively) and PDR (p=0.0108 and p=0.0332 respectively) subjects than those were considered as DNR. CONCLUSIONS: Our findings suggest that N(ε)-CML and ROS are the key modulators for the development of nonproliferative retinopathy among poorly controlled type 2 diabetic subjects. Furthermore, AGEs under persistent oxidative stress and the deprived antioxidant state might instigate the pathogenic process of retinopathy from the nonproliferative to the proliferative state.
format Online
Article
Text
id pubmed-3559098
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-35590982013-02-01 Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus Choudhuri, Subhadip Dutta, Deep Sen, Aditi Chowdhury, Imran Hussain Mitra, Bhaskar Mondal, Lakshmi Kanta Saha, Avijit Bhadhuri, Gautam Bhattacharya, Basudev Mol Vis Research Article PURPOSE: The aim of the present study was to evaluate the collective role of N-epsilon–carboxy methyl lysine (N(ε)-CML), advanced glycation end-products (AGEs), and reactive oxygen species (ROS) for the development of retinopathy among type 2 diabetic subjects. METHODS: Seventy type 2 diabetic subjects with nonproliferative diabetic retinopathy (NPDR), 105 subjects with proliferative diabetic retinopathy (PDR), and 102 patients with diabetes but without retinopathy (DNR) were enrolled in this study. In addition, 95 normal individuals without diabetes were enrolled as healthy controls in this study. Serum and vitreous N(ε)-CML and AGEs were measured by enzyme-linked immunosorbent assay. The peripheral blood mononuclear cell (PBMC) ROS level was measured by flow cytometric analysis. Serum and PBMC total thiols were measured by spectrophotometry. RESULTS: Serum AGEs and N(ε)-CML levels were significantly elevated in subjects with PDR (p<0.0001) and NPDR (p=0.0297 and p<0.0001, respectively) compared to DNR subjects. Further vitreous AGEs and N(ε)-CML levels were found to be significantly high among PDR subjects compared to the control group (p<0.0001). PBMC ROS production was found to be strikingly high among NPDR (p<0.0001) and PDR (p<0.0001) subjects as compared to the DNR group. Serum and PBMC total thiol levels were remarkably decreased in NPDR (p<0.0001 and p=0.0043, respectively) and PDR (p=0.0108 and p=0.0332 respectively) subjects than those were considered as DNR. CONCLUSIONS: Our findings suggest that N(ε)-CML and ROS are the key modulators for the development of nonproliferative retinopathy among poorly controlled type 2 diabetic subjects. Furthermore, AGEs under persistent oxidative stress and the deprived antioxidant state might instigate the pathogenic process of retinopathy from the nonproliferative to the proliferative state. Molecular Vision 2013-01-28 /pmc/articles/PMC3559098/ /pubmed/23378723 Text en Copyright © 2013 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Choudhuri, Subhadip
Dutta, Deep
Sen, Aditi
Chowdhury, Imran Hussain
Mitra, Bhaskar
Mondal, Lakshmi Kanta
Saha, Avijit
Bhadhuri, Gautam
Bhattacharya, Basudev
Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
title Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
title_full Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
title_fullStr Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
title_full_unstemmed Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
title_short Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
title_sort role of n–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559098/
https://www.ncbi.nlm.nih.gov/pubmed/23378723
work_keys_str_mv AT choudhurisubhadip roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT duttadeep roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT senaditi roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT chowdhuryimranhussain roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT mitrabhaskar roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT mondallakshmikanta roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT sahaavijit roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT bhadhurigautam roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus
AT bhattacharyabasudev roleofnepsiloncarboxymethyllysineadvancedglycationendproductsandreactiveoxygenspeciesforthedevelopmentofnonproliferativeandproliferativeretinopathyintype2diabetesmellitus